Location History:
- München, DE (2009)
- Planegg, DE (2012 - 2022)
Company Filing History:
3 out of 88 
2 out of 15 
1 out of 1 
Years Active: 2009-2022
Title: Andreas Bültmann: A Patent Innovator in the Field of Biotechnology
Introduction:
In the fast-paced world of biotechnology, where breakthroughs can revolutionize healthcare, we find remarkable individuals like Andreas Bültmann. Hailing from Planegg, Germany, Bültmann has made significant contributions to the field through his innovative patents and collaborations with prominent companies. Let us delve deeper into his latest patents, career highlights, and noteworthy collaborations.
Latest Patents:
Andreas Bültmann has been involved in various groundbreaking research and development projects, resulting in several noteworthy patents. One of his recent patents focuses on humanized antibodies for CD3. The patent describes the creation of antibodies that efficiently target high-expressing tumor-related antigens while exhibiting limited killing activity on low-expressing cells. These humanized antibodies hold great potential for effective T cell-mediated killing of cancer cells.
Another significant patent authored by Bültmann is related to a polypeptide library. This invention revolves around unique conformationally constrained polypeptide libraries arranged in an anti-parallel, helix-turn-helix structure. These libraries can be utilized for diverse applications such as drug discovery, diagnostics, and other pharmaceutical uses.
Career Highlights:
Bültmann's career has been marked by remarkable achievements in the biotechnology industry. He has actively contributed to renowned companies, notably including Morphosys AG and Trigen GmbH. During his tenure with these organizations, Bültmann has played a vital role in enhancing their patent portfolios and driving innovation in the field.
Collaborations:
Collaboration plays a crucial role in the advancement of scientific and technological discoveries, and Andreas Bültmann recognizes the value of working with talented peers. Throughout his career, he has collaborated with notable industry experts, including Götz Münch and Meinrad Gawaz. These collaborations have resulted in synergistic efforts and groundbreaking inventions.
Conclusion:
Andreas Bültmann's innovative contributions to the field of biotechnology have established him as a notable figure in the industry. With several patents to his name, including the development of humanized antibodies for CD3 and novel polypeptide libraries, Bültmann has showcased his expertise in creating solutions for complex challenges. His collaborations with esteemed colleagues further reinforce his commitment to advancing scientific knowledge and fostering technological progress. We eagerly anticipate future breakthroughs from this visionary inventor as he continues to push boundaries and redefine the field of biotechnology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.